Insider Transactions in Q4 2022 at Clearside Biomedical, Inc. (CLSD)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2022
|
Thomas Ciulla Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+1.6%
|
$0
$0.95 P/Share
|
|
Dec 21
2022
|
Clay Thorp |
BUY
Open market or private purchase
|
Direct |
14,000
+31.45%
|
$14,000
$1.02 P/Share
|
|
Dec 20
2022
|
Charles A. Deignan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,636
+5.89%
|
$0
$0.4 P/Share
|
|
Dec 15
2022
|
Clay Thorp |
BUY
Other acquisition or disposition
|
Direct |
8,522
+34.03%
|
-
|
|
Dec 15
2022
|
Clay Thorp |
SELL
Other acquisition or disposition
|
Indirect |
1,406,507
-28.41%
|
-
|
|
Nov 17
2022
|
Nancy J Hutson |
BUY
Open market or private purchase
|
Direct |
30,000
+26.55%
|
$30,000
$1.33 P/Share
|